168 related articles for article (PubMed ID: 24372710)
1. Predictive immunogenicity of Refacto AF.
Delignat S; Repessé Y; Gilardin L; Dimitrov JD; Lone YC; Kaveri SV; Lacroix-Desmazes S
Haemophilia; 2014 Jul; 20(4):486-92. PubMed ID: 24372710
[TBL] [Abstract][Full Text] [Related]
2. ReFacto and Advate: a single-dose, randomized, two-period crossover pharmacokinetics study in subjects with haemophilia A.
Di Paola J; Smith MP; Klamroth R; Mannucci PM; Kollmer C; Feingold J; Kessler C; Pollmann H; Morfini M; Udata C; Rothschild C; Hermans C; Janco R
Haemophilia; 2007 Mar; 13(2):124-30. PubMed ID: 17286764
[TBL] [Abstract][Full Text] [Related]
3. Biochemical characterization and immunogenicity of Neureight, a recombinant full-length factor VIII produced by fed-batch process in disposable bioreactors.
Delignat S; Peyron I; El Ghazaly M; V Kaveri S; Rohde J; Mueller F; Lacroix-Desmazes S
Cell Immunol; 2018 Sep; 331():22-29. PubMed ID: 29751951
[TBL] [Abstract][Full Text] [Related]
4. Uptake of blood coagulation factor VIII by dendritic cells is mediated via its C1 domain.
Herczenik E; van Haren SD; Wroblewska A; Kaijen P; van den Biggelaar M; Meijer AB; Martinez-Pomares L; ten Brinke A; Voorberg J
J Allergy Clin Immunol; 2012 Feb; 129(2):501-9, 509.e1-5. PubMed ID: 21962992
[TBL] [Abstract][Full Text] [Related]
5. Factor VIII assay variability in postinfusion samples containing full length and B-domain deleted FVIII.
Kitchen S; Jennings I; Makris M; Kitchen DP; Woods TA; Walker ID
Haemophilia; 2016 Sep; 22(5):806-12. PubMed ID: 27217329
[TBL] [Abstract][Full Text] [Related]
6. Removal of Mannose-Ending Glycan at Asn
Delignat S; Rayes J; Dasgupta S; Gangadharan B; Denis CV; Christophe OD; Bayry J; Kaveri SV; Lacroix-Desmazes S
Front Immunol; 2020; 11():393. PubMed ID: 32273875
[TBL] [Abstract][Full Text] [Related]
7. Factor VIII products and inhibitor development in previously treated patients with severe or moderately severe hemophilia A: a systematic review.
Hassan S; Cannavò A; Gouw SC; Rosendaal FR; van der Bom JG
J Thromb Haemost; 2018 Jun; 16(6):1055-1068. PubMed ID: 29665204
[TBL] [Abstract][Full Text] [Related]
8. The use of the new ReFacto AF Laboratory Standard allows reliable measurement of FVIII:C levels in ReFacto AF mock plasma samples by a one-stage clotting assay.
Pouplard C; Caron C; Aillaud MF; Ternisien C; Desconclois C; Dubanchet A; Sobas F
Haemophilia; 2011 Sep; 17(5):e958-62. PubMed ID: 21457408
[TBL] [Abstract][Full Text] [Related]
9. The incidence of factor VIII inhibitors in severe haemophilia A following a major switch from full-length to B-domain-deleted factor VIII: a prospective cohort comparison.
Hay CRM; Palmer BP; Chalmers EA; Hart DP; Liesner R; Rangarajan S; Talks K; Williams M; Collins PW
Haemophilia; 2015 Mar; 21(2):219-226. PubMed ID: 25382829
[TBL] [Abstract][Full Text] [Related]
10. To serve and protect: The modulatory role of von Willebrand factor on factor VIII immunogenicity.
Hartholt RB; van Velzen AS; Peyron I; Ten Brinke A; Fijnvandraat K; Voorberg J
Blood Rev; 2017 Sep; 31(5):339-347. PubMed ID: 28716211
[TBL] [Abstract][Full Text] [Related]
11. Factor VIII inhibitors: role of von Willebrand factor on the uptake of factor VIII by dendritic cells.
Kaveri SV; Dasgupta S; Andre S; Navarrete AM; Repessé Y; Wootla B; Lacroix-Desmazes S
Haemophilia; 2007 Dec; 13 Suppl 5():61-4. PubMed ID: 18078399
[TBL] [Abstract][Full Text] [Related]
12. A role for exposed mannosylations in presentation of human therapeutic self-proteins to CD4+ T lymphocytes.
Dasgupta S; Navarrete AM; Bayry J; Delignat S; Wootla B; André S; Christophe O; Nascimbeni M; Jacquemin M; Martinez-Pomares L; Geijtenbeek TB; Moris A; Saint-Remy JM; Kazatchkine MD; Kaveri SV; Lacroix-Desmazes S
Proc Natl Acad Sci U S A; 2007 May; 104(21):8965-70. PubMed ID: 17502612
[TBL] [Abstract][Full Text] [Related]
13. Performance of recalibrated ReFacto laboratory standard in the measurement of FVIII plasma concentration via the chromogenic and one-stage assays after infusion of recalibrated ReFacto (B-domain deleted recombinant factor VIII).
Santoro C; Iorio A; Ferrante F; Pallotta A; Pignoloni P; Biondo F; Agnelli G; Mazzucconi MG
Haemophilia; 2009 May; 15(3):779-87. PubMed ID: 19298379
[TBL] [Abstract][Full Text] [Related]
14. Preclinical efficacy and safety of rVIII-SingleChain (CSL627), a novel recombinant single-chain factor VIII.
Zollner SB; Raquet E; Müller-Cohrs J; Metzner HJ; Weimer T; Pragst I; Dickneite G; Schulte S
Thromb Res; 2013 Aug; 132(2):280-7. PubMed ID: 23830969
[TBL] [Abstract][Full Text] [Related]
15. Immunoprotective effect of von Willebrand factor towards therapeutic factor VIII in experimental haemophilia A.
Delignat S; Repessé Y; Navarrete AM; Meslier Y; Gupta N; Christophe OD; Kaveri SV; Lacroix-Desmazes S
Haemophilia; 2012 Mar; 18(2):248-54. PubMed ID: 22044692
[TBL] [Abstract][Full Text] [Related]
16. The immunogenicity of ReFacto AF (moroctocog alfa AF-CC) in previously untreated patients with haemophilia A in the United Kingdom.
Mathias MC; Collins PW; Palmer BP; Chalmers E; Alamelu J; Richards M; Will A; Hay CRM;
Haemophilia; 2018 Nov; 24(6):896-901. PubMed ID: 30004617
[TBL] [Abstract][Full Text] [Related]
17. Danger signal-dependent activation of human dendritic cells by plasma-derived factor VIII products.
Miller L; Weissmüller S; Ringler E; Crauwels P; van Zandbergen G; Seitz R; Waibler Z;
Thromb Haemost; 2015 Aug; 114(2):268-76. PubMed ID: 25947149
[TBL] [Abstract][Full Text] [Related]
18. Identification of aggregates in therapeutic formulations of recombinant full-length factor VIII products by sedimentation velocity analytical ultracentrifugation.
Healey JF; Parker ET; Lollar P
J Thromb Haemost; 2018 Feb; 16(2):303-315. PubMed ID: 29197156
[TBL] [Abstract][Full Text] [Related]
19. Individual combinations of danger signals synergistically increase FVIII product immunogenicity.
Miller L; Klemm J; Schmidt C; Hanschmann KM; Bekeredjian-Ding I; Waibler Z
Haemophilia; 2019 Nov; 25(6):996-1002. PubMed ID: 31584736
[TBL] [Abstract][Full Text] [Related]
20. The role of VWF in the immunogenicity of FVIII.
Lacroix-Desmazes S; Repessé Y; Kaveri SV; Dasgupta S
Thromb Res; 2008; 122 Suppl 2():S3-6. PubMed ID: 18549909
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
